Literature DB >> 434944

Mechanism and treatment of hypertriglyceridaemia in gout.

T Gibson, K Kilbourn, I Horner, H A Simmonds.   

Abstract

Using the Intralipid lipid tolerance test we could not demonstrate any direct effect of serum triglyceride on uric acid or any influence of hyperuricaemia on triglyceride removal. This result supports previous studies suggesting that hyperuricaemia and hypertriglyceridaemia are linked through the association of obesity and alcohol excess rather than a direct cause and effect mechanism. It was possible to demonstrate significant reductions of serum triglyceride in patients with gout by reducing either their alcohol intake or body weight. Reduction of serum uric acid by probenecid had no effect on serum triglyceride or cholesterol. Similarly, allopurinol had no significant effect on serum triglyceride, but a significant fall of serum cholesterol was observed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 434944      PMCID: PMC1000314          DOI: 10.1136/ard.38.1.31

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  34 in total

1.  AUTOMATED DETERMINATION OF SERUM TOTAL CHOLESTEROL.

Authors:  J B LEVINE; B ZAK
Journal:  Clin Chim Acta       Date:  1964-10       Impact factor: 3.786

2.  STUDIES OF ALCOHOLIC HYPERLIPEMIA AND ITS MECHANISM.

Authors:  M S LOSOWSKY; D P JONES; C S DAVIDSON; C S LIEBER
Journal:  Am J Med       Date:  1963-12       Impact factor: 4.965

3.  HYPERTRIGLYCERIDEMIA IN GOUT.

Authors:  E B FELDMAN; S L WALLACE
Journal:  Circulation       Date:  1964-04       Impact factor: 29.690

4.  Interrelation of uric acid and ethanol metabolism in man.

Authors:  C S LIEBER; D P JONES; M S LOSOWSKY; C S DAVIDSON
Journal:  J Clin Invest       Date:  1962-10       Impact factor: 14.808

5.  Hepatic lipid metabolism in severe human obesity.

Authors:  J G Kral; K Lundholm; P Björntorp; L Sjöström; T Scherstén
Journal:  Metabolism       Date:  1977-09       Impact factor: 8.694

6.  Nocturnal hypertriglyceridemia and hyperinsulinemia following moderate evening intake of alcohol.

Authors:  M R Taskinen; E A Nikkilä
Journal:  Acta Med Scand       Date:  1977

7.  Hypertriglyceridaemia and hyperuricaemia.

Authors:  R S Elkeles; R A Chalmers
Journal:  Lancet       Date:  1977-07-30       Impact factor: 79.321

8.  Dietary treatment of type IV hyperlipoproteinemia.

Authors:  A M Gotto; M E DeBakey; J P Foreyt; L W Scott; J I Thornby
Journal:  JAMA       Date:  1977-03-21       Impact factor: 56.272

9.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

10.  Association of serum lipids and obesity with cardiovascular mortality.

Authors:  R Pelkonen; E A Nikkilä; S Koskinen; K Penttinen; S Sarna
Journal:  Br Med J       Date:  1977-11-05
View more
  11 in total

1.  Hyperlipidaemia in hyperuricaemia and gout.

Authors:  B Emmerson
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

2.  Decreased triglyceride levels with low calorie diet and increased renal excretion of uric acid in hyperuricaemic-hyperlipidaemic patients.

Authors:  F J Tinahones; F J Soriguer; E Collantes; G Pérez-Lindón; P Sánchez Guijo; J A Lillo
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

3.  A controlled study of diet in patients with gout.

Authors:  T Gibson; A V Rodgers; H A Simmonds; F Court-Brown; E Todd; V Meilton
Journal:  Ann Rheum Dis       Date:  1983-04       Impact factor: 19.103

4.  Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses.

Authors:  Karen L Teff; Joanne Grudziak; Raymond R Townsend; Tamara N Dunn; Ryan W Grant; Sean H Adams; Nancy L Keim; Bethany P Cummings; Kimber L Stanhope; Peter J Havel
Journal:  J Clin Endocrinol Metab       Date:  2009-02-10       Impact factor: 5.958

5.  Serum lipids and lipoproteins in patients with primary gout.

Authors:  A Ulreich; G M Kostner; K P Pfeiffer; P Sedlmayr; F Rainer
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

6.  Alcohol consumption in arthritic patients: clinical and laboratory studies.

Authors:  A Bradlow; A G Mowat
Journal:  Ann Rheum Dis       Date:  1985-03       Impact factor: 19.103

7.  Hyperlipoproteinaemia in primary gout: hyperlipoproteinaemic phenotype and influence of alcohol intake and obesity in Japan.

Authors:  S Jiao; K Kameda; Y Matsuzawa; S Tarui
Journal:  Ann Rheum Dis       Date:  1986-04       Impact factor: 19.103

8.  Apolipoprotein E phenotypes in patients with gout: relation with hypertriglyceridaemia.

Authors:  Y Moriwaki; T Yamamoto; S Takahashi; Z Tsutsumi; K Higashino
Journal:  Ann Rheum Dis       Date:  1995-05       Impact factor: 19.103

9.  Serum uric acid and risk of incident hypercholesterolaemia and hypertriglyceridaemia in middle-aged and older Chinese: a 4-year prospective cohort study.

Authors:  Yanzhi Li; Lu Tian; Han Zheng; Chongqi Jia
Journal:  Ann Med       Date:  2020-07-22       Impact factor: 4.709

10.  Allopurinol treatment and its effect on renal function in gout: a controlled study.

Authors:  T Gibson; V Rodgers; C Potter; H A Simmonds
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.